Literature DB >> 15134787

Protein kinase C family functions in B-cell activation.

Beichu Guo1, Thomas T Su, David J Rawlings.   

Abstract

Members of the protein kinase C (PKC) family play important but distinct roles in B-cell activation, as demonstrated by emerging genetic and biochemical studies. PKCbeta is indispensable for B-cell antigen receptor (BCR)-induced NF-kappaB activation and B-cell survival. Recent evidence indicates that PKCbeta might regulate inhibitor of kappaB kinase (IKK) and NF-kappaB activation through interaction with the CARMA1/Bcl10/MALT signaling complex in BCR microdomains. By contrast, the novel PKC isoform PKCdelta is specifically required to maintain the tolerance of self-reactive B cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15134787     DOI: 10.1016/j.coi.2004.03.012

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  33 in total

1.  Syk mediates BCR- and CD40-signaling integration during B cell activation.

Authors:  Haiyan Ying; Zhenping Li; Lifen Yang; Jian Zhang
Journal:  Immunobiology       Date:  2010-10-07       Impact factor: 3.144

2.  The serine-threonine kinase p90RSK is a new target of enzastaurin in follicular lymphoma cells.

Authors:  S Kheirallah; S Fruchon; L Ysebaert; A Blanc; F Capilla; A Marrot; T Alsaati; F X Frenois; K A Benhadji; J J Fournié; G Laurent; C Bezombes
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

3.  Diacylglycerol kinase ζ limits B cell antigen receptor-dependent activation of ERK signaling to inhibit early antibody responses.

Authors:  Matthew L Wheeler; Matthew B Dong; Robert Brink; Xiao-Ping Zhong; Anthony L DeFranco
Journal:  Sci Signal       Date:  2013-10-15       Impact factor: 8.192

4.  Loss-of-function of the protein kinase C δ (PKCδ) causes a B-cell lymphoproliferative syndrome in humans.

Authors:  Hye Sun Kuehn; Julie E Niemela; Andreia Rangel-Santos; Mingchang Zhang; Stefania Pittaluga; Jennifer L Stoddard; Ashleigh A Hussey; Moses O Evbuomwan; Debra A Long Priel; Douglas B Kuhns; C Lucy Park; Thomas A Fleisher; Gulbu Uzel; João B Oliveira
Journal:  Blood       Date:  2013-02-21       Impact factor: 22.113

5.  Signal Transduction in Immune Cells and Protein Kinases.

Authors:  Monica Neagu; Carolina Constantin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  PKK deficiency in B cells prevents lupus development in Sle lupus mice.

Authors:  D Oleksyn; J Zhao; A Vosoughi; J C Zhao; R Misra; A P Pentland; D Ryan; J Anolik; C Ritchlin; J Looney; A P Anandarajah; G Schwartz; L M Calvi; M Georger; C Mohan; I Sanz; L Chen
Journal:  Immunol Lett       Date:  2017-03-06       Impact factor: 3.685

7.  Systematic comparison of gene expression between murine memory and naive B cells demonstrates that memory B cells have unique signaling capabilities.

Authors:  Mary M Tomayko; Shannon M Anderson; Catherine E Brayton; Saheli Sadanand; Natalie C Steinel; Timothy W Behrens; Mark J Shlomchik
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

8.  B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C δ.

Authors:  Elisabeth Salzer; Elisangela Santos-Valente; Stefanie Klaver; Sol A Ban; Wolfgang Emminger; Nina Kathrin Prengemann; Wojciech Garncarz; Leonhard Müllauer; Renate Kain; Heidrun Boztug; Andreas Heitger; Klaus Arbeiter; Franz Eitelberger; Markus G Seidel; Wolfgang Holter; Arnold Pollak; Winfried F Pickl; Elisabeth Förster-Waldl; Kaan Boztug
Journal:  Blood       Date:  2013-01-14       Impact factor: 22.113

9.  Protein kinase Cβ is required for lupus development in Sle mice.

Authors:  David Oleksyn; Mary Pulvino; Jiyong Zhao; Ravi Misra; Aram Vosoughi; Scott Jenks; Christopher Tipton; Frances Lund; George Schwartz; Bruce Goldman; Chandra Mohan; Kamal Mehta; Madhu Mehta; Michael Leitgets; Ignacio Sanz; Luojing Chen
Journal:  Arthritis Rheum       Date:  2013-04

10.  The PKC inhibitor AEB071 may be a therapeutic option for psoriasis.

Authors:  Hans Skvara; Markus Dawid; Elise Kleyn; Barbara Wolff; Josef G Meingassner; Hilary Knight; Thomas Dumortier; Tamara Kopp; Nasanin Fallahi; Georg Stary; Christoph Burkhart; Olivier Grenet; Juergen Wagner; Youssef Hijazi; Randall E Morris; Claire McGeown; Christiane Rordorf; Christopher E M Griffiths; Georg Stingl; Thomas Jung
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.